Published in N Engl J Med on March 31, 2014
Impact of Plasma Soluble Prorenin Receptor in Obese and Type 2 Diabetic Patients | NCT03643783
Weight Loss and Health Status 3 Years after Bariatric Surgery in Adolescents. N Engl J Med (2015) 4.35
Three-Year Outcomes of Bariatric Surgery vs Lifestyle Intervention for Type 2 Diabetes Mellitus Treatment: A Randomized Clinical Trial. JAMA Surg (2015) 3.67
Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes. N Engl J Med (2017) 3.53
Roux-en-Y gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trial. Lancet Diabetes Endocrinol (2015) 1.64
Bile diversion to the distal small intestine has comparable metabolic benefits to bariatric surgery. Nat Commun (2015) 1.57
Bariatric Surgery in the United Kingdom: A Cohort Study of Weight Loss and Clinical Outcomes in Routine Clinical Care. PLoS Med (2015) 1.50
Lifestyle and diet. Cardiovasc J Afr (2015) 1.39
Simplified gastric bypass: 13 years of experience and 12,000 patients operated. Arq Bras Cir Dig (2014) 1.10
Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial. Diabetologia (2016) 1.09
Bariatric/Metabolic Surgery to Treat Type 2 Diabetes in Patients With a BMI <35 kg/m2. Diabetes Care (2016) 1.00
Bariatric surgery versus intensive medical therapy for diabetes. N Engl J Med (2014) 0.98
Laparoscopic sleeve gastrectomy: More than a restrictive bariatric surgery procedure? World J Gastroenterol (2015) 0.98
Bile acids, obesity, and the metabolic syndrome. Best Pract Res Clin Gastroenterol (2014) 0.94
The physiology underlying Roux-en-Y gastric bypass: a status report. Am J Physiol Regul Integr Comp Physiol (2014) 0.93
β-cell dysfunction: Its critical role in prevention and management of type 2 diabetes. World J Diabetes (2015) 0.92
The role of bile acids in reducing the metabolic complications of obesity after bariatric surgery: a systematic review. Int J Obes (Lond) (2015) 0.92
Preoperative β-cell function in patients with type 2 diabetes is important for the outcome of Roux-en-Y gastric bypass surgery. J Physiol (2015) 0.91
Early onset type 2 diabetes: risk factors, clinical impact and management. Ther Adv Chronic Dis (2014) 0.91
Leptin deficient ob/ob mice and diet-induced obese mice responded differently to Roux-en-Y bypass surgery. Int J Obes (Lond) (2014) 0.90
Bariatric surgery versus intensive medical therapy for diabetes. N Engl J Med (2014) 0.90
Peripheral mechanisms in appetite regulation. Gastroenterology (2014) 0.90
Bariatric and metabolic surgery: a shift in eligibility and success criteria. Nat Rev Endocrinol (2015) 0.89
Vagal innervation of intestine contributes to weight loss After Roux-en-Y gastric bypass surgery in rats. Obes Surg (2014) 0.89
Bariatric surgery versus intensive medical therapy for diabetes. N Engl J Med (2014) 0.89
Bariatric surgery versus intensive medical therapy for diabetes. N Engl J Med (2014) 0.89
TGR5 contributes to glucoregulatory improvements after vertical sleeve gastrectomy in mice. Gut (2015) 0.89
Endoscopic Sleeve Gastroplasty for Obesity: a Multicenter Study of 248 Patients with 24 Months Follow-Up. Obes Surg (2017) 0.88
Adults with long-duration type 2 diabetes have blunted glycemic and β-cell function improvements after bariatric surgery. Obesity (Silver Spring) (2015) 0.88
Mechanisms underlying weight loss and metabolic improvements in rodent models of bariatric surgery. Diabetologia (2014) 0.87
Long-term effects of laparoscopic sleeve gastrectomy versus roux-en-Y gastric bypass for the treatment of Chinese type 2 diabetes mellitus patients with body mass index 28-35 kg/m(2). BMC Surg (2015) 0.87
Temporal changes in bile acid levels and 12α-hydroxylation after Roux-en-Y gastric bypass surgery in type 2 diabetes. Int J Obes (Lond) (2015) 0.86
Bariatric surgery versus intensive medical therapy for diabetes. N Engl J Med (2014) 0.85
Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations. Circulation (2016) 0.84
Treatment of Obesity: Weight Loss and Bariatric Surgery. Circ Res (2016) 0.83
Metabolic Surgery for Type 2 Diabetes: Changing the Landscape of Diabetes Care. Diabetes Care (2016) 0.83
Bariatric Surgery and Long-term Durability of Weight Loss. JAMA Surg (2016) 0.83
BariSurg trial: Sleeve gastrectomy versus Roux-en-Y gastric bypass in obese patients with BMI 35-60 kg/m(2) - a multi-centre randomized patient and observer blind non-inferiority trial. BMC Surg (2015) 0.83
Is Bariatric Surgery an Effective Treatment for Type II Diabetic Kidney Disease? Clin J Am Soc Nephrol (2015) 0.83
Clinician's guide to the updated ABCs of cardiovascular disease prevention. J Am Heart Assoc (2014) 0.82
Recent advances in bariatric/metabolic surgery: appraisal of clinical evidence. J Biomed Res (2014) 0.82
Type 2 Diabetes Remission Rates After Laparoscopic Gastric Bypass and Gastric Banding: Results of the Longitudinal Assessment of Bariatric Surgery Study. Diabetes Care (2016) 0.82
Chenodeoxycholic acid stimulates glucagon-like peptide-1 secretion in patients after Roux-en-Y gastric bypass. Physiol Rep (2017) 0.82
Bariatric surgery, kidney function, insulin resistance, and adipokines in patients with decreased GFR: a cohort study. Am J Kidney Dis (2014) 0.82
Attenuated improvements in adiponectin and fat loss characterize type 2 diabetes non-remission status after bariatric surgery. Diabetes Obes Metab (2014) 0.82
Metabolic bariatric surgery and type 2 diabetes mellitus: an endocrinologist's perspective. J Biomed Res (2015) 0.81
Insulin Sensitivity and β-Cell Function Improve after Gastric Bypass in Severely Obese Adolescents. J Pediatr (2015) 0.81
Five-year outcomes of laparoscopic sleeve gastrectomy as a primary procedure for morbid obesity: A prospective study. World J Gastrointest Surg (2017) 0.81
Surgical models of Roux-en-Y gastric bypass surgery and sleeve gastrectomy in rats and mice. Nat Protoc (2015) 0.81
Durability of Addition of Roux-en-Y Gastric Bypass to Lifestyle Intervention and Medical Management in Achieving Primary Treatment Goals for Uncontrolled Type 2 Diabetes in Mild to Moderate Obesity: A Randomized Control Trial. Diabetes Care (2016) 0.80
Laparoscopic sleeve gastrectomy and gastroesophageal reflux. World J Gastroenterol (2015) 0.80
Bariatric surgery is associated with improvement in kidney outcomes. Kidney Int (2016) 0.80
Bariatric surgery and diabetes remission: Who would have thought it? Indian J Endocrinol Metab (2015) 0.80
Predictors of readmission after laparoscopic gastric bypass and sleeve gastrectomy: a comparative analysis of ACS-NSQIP database. Surg Endosc (2015) 0.80
Patient and Referring Practitioner Characteristics Associated With the Likelihood of Undergoing Bariatric Surgery: A Systematic Review. JAMA Surg (2015) 0.80
Comparative effectiveness and safety of gastric bypass, sleeve gastrectomy and adjustable gastric banding in a population-based bariatric program: prospective cohort study. Can J Surg (2016) 0.80
Safety analysis of primary bariatric surgery in patients on chronic dialysis. Surg Endosc (2015) 0.80
LAP-BAND for BMI 30-40: 5-year health outcomes from the multicenter pivotal study. Int J Obes (Lond) (2015) 0.79
Effect of bariatric surgery on cardiometabolic risk in elderly patients: A population-based study. Geriatr Gerontol Int (2015) 0.79
Foregut exclusion disrupts intestinal glucose sensing and alters portal nutrient and hormonal milieu. Diabetes (2015) 0.79
Challenging obesity: Patient, provider, and expert perspectives on the roles of available and emerging nonsurgical therapies. Obesity (Silver Spring) (2015) 0.79
The comprehensive summary of surgical versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomized controlled trials. Oncotarget (2016) 0.79
C1q/TNF-Related Protein-9 (CTRP9) Levels Are Associated With Obesity and Decrease Following Weight Loss Surgery. J Clin Endocrinol Metab (2016) 0.79
Long-term Microvascular Disease Outcomes in Patients With Type 2 Diabetes After Bariatric Surgery: Evidence for the Legacy Effect of Surgery. Diabetes Care (2016) 0.79
Cardiovascular and renal effects of weight reduction in obesity and the metabolic syndrome. Curr Hypertens Rep (2015) 0.79
Laparoscopic Sleeve Gastrectomy Versus Roux-Y-Gastric Bypass for Morbid Obesity-3-Year Outcomes of the Prospective Randomized Swiss Multicenter Bypass Or Sleeve Study (SM-BOSS). Ann Surg (2017) 0.79
The Effect of Bariatric Surgery on Diabetic Retinopathy: Good, Bad, or Both? Diabetes Metab J (2016) 0.79
Bariatric Surgery Induces Disruption in Inflammatory Signaling Pathways Mediated by Immune Cells in Adipose Tissue: A RNA-Seq Study. PLoS One (2015) 0.78
Metabolic Surgery for Type 2 Diabetes Mellitus: Experience from Asia. Diabetes Metab J (2016) 0.78
Cardiovascular effects of bariatric surgery. Nat Rev Cardiol (2016) 0.78
Duodenal stump leak following a duodenal switch: A case report. Int J Surg Case Rep (2015) 0.78
Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology. World J Gastroenterol (2015) 0.78
Effect of Roux-en-Y gastric bypass and laparoscopic adjustable gastric banding on gastrointestinal metabolism of ingested glucose. Am J Clin Nutr (2015) 0.78
THE ROLE OF METABOLIC SURGERY FOR PATIENTS WITH OBESITY GRADE I AND TYPE 2 DIABETES NOT CONTROLLED CLINICALLY. Arq Bras Cir Dig (2016) 0.78
Roux-en-Y Gastric Bypass Versus Medical Treatment for Type 2 Diabetes Mellitus in Obese Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicine (Baltimore) (2016) 0.78
Interaction of obesity and inflammatory bowel disease. World J Gastroenterol (2016) 0.77
RYGB progressively increases avidity for a low-energy, artificially sweetened diet in female rats. Appetite (2015) 0.77
Metabolic Surgery for Diabetes Treatment: Sleeve Gastrectomy or Gastric Bypass? World J Surg (2017) 0.77
STAMPEDE: Bariatric surgery gains more evidence based support. Glob Cardiol Sci Pract (2014) 0.77
Sleeve gastrectomy, but not duodenojejunostomy, preserves total beta-cell mass in Goto-Kakizaki rats evaluated by three-dimensional optical projection tomography. Surg Endosc (2015) 0.77
Mechanisms of surgical control of type 2 diabetes: GLP-1 is the key factor-Maybe. Surg Obes Relat Dis (2016) 0.77
Failed Surgical Weight Loss Does Not Necessarily Mean Failed Metabolic Effects. Diabetes Technol Ther (2015) 0.77
Improvement in severe pulmonary hypertension in obese patients after laparoscopic gastric bypass or sleeve gastrectomy. Surg Endosc (2015) 0.77
Leptin Is Required for Glucose Homeostasis after Roux-en-Y Gastric Bypass in Mice. PLoS One (2015) 0.77
Hypovitaminosis D in bariatric surgery: A systematic review of observational studies. Metabolism (2015) 0.77
Assessing the obese diabetic patient for bariatric surgery: which candidate do I choose? Diabetes Metab Syndr Obes (2015) 0.77
Laparoscopic Roux-en-Y gastric bypass patients have an increased lifetime risk of repeat operations when compared to laparoscopic sleeve gastrectomy patients. Surg Endosc (2015) 0.77
A working paradigm for the treatment of obesity in gastrointestinal practice. Tech Gastrointest Endosc (2017) 0.77
Longer-Term Physiological and Metabolic Effects of Gastric Bypass Surgery. Curr Diab Rep (2016) 0.77
Type 1 Diabetes Mellitus and Bariatric Surgery: A Systematic Review and Meta-Analysis. Obes Surg (2016) 0.76
Relationship between gut hormones and glucose homeostasis after bariatric surgery. Diabetol Metab Syndr (2014) 0.76
Risk of post-gastric bypass surgery hypoglycemia in nondiabetic individuals: A single center experience. Obesity (Silver Spring) (2016) 0.76
The metabolic vascular syndrome - guide to an individualized treatment. Rev Endocr Metab Disord (2016) 0.76
Obesity and liver transplantation. World J Transplant (2015) 0.76
A new noninvasive technique for estimating hepatic triglyceride: will liver biopsy become redundant in diagnosing non-alcoholic fatty liver disease? BMC Med (2014) 0.76
Clinical Outcomes of Metabolic Surgery: Microvascular and Macrovascular Complications. Diabetes Care (2016) 0.76
The Short-Term Remission of Diabetic Nephropathy After Roux-en-Y Gastric Bypass in Chinese Patients of T2DM with Obesity. Obes Surg (2015) 0.76
Sympathetic inhibition after bariatric surgery. Hypertension (2014) 0.76
Bariatric Surgery Restores Cardiac and Sudomotor Autonomic C-Fiber Dysfunction towards Normal in Obese Subjects with Type 2 Diabetes. PLoS One (2016) 0.76
A novel multidisciplinary intervention for long-term weight loss and glycaemic control in obese patients with diabetes. J Diabetes Res (2015) 0.76
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med (2007) 33.21
Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med (2012) 13.59
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. N Engl J Med (2013) 11.34
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA (2006) 9.27
Alogliptin after acute coronary syndrome in patients with type 2 diabetes. N Engl J Med (2013) 8.74
Long-term use of ticagrelor in patients with prior myocardial infarction. N Engl J Med (2015) 8.69
Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest. JAMA (2009) 8.56
Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med (2011) 7.30
Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis. PLoS Med (2009) 6.89
Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation (2011) 6.36
Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves. N Engl J Med (2015) 6.28
Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. JAMA (2007) 5.89
Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med (2003) 5.89
Troponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes. N Engl J Med (2015) 5.81
One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA (2007) 5.61
Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ (2013) 5.08
β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA (2012) 4.92
Apixaban with antiplatelet therapy after acute coronary syndrome. N Engl J Med (2011) 4.81
Effects of CYP2C19 genotype on outcomes of clopidogrel treatment. N Engl J Med (2010) 4.73
Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial. Lancet (2010) 4.72
Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis. N Engl J Med (2003) 4.61
Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. N Engl J Med (2012) 4.49
Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation (2002) 4.31
Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus. JAMA (2005) 4.23
Medical device recalls and the FDA approval process. Arch Intern Med (2011) 4.01
Frequent ventricular ectopy after exercise as a predictor of death. N Engl J Med (2003) 3.87
Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality. Arch Intern Med (2010) 3.79
Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med (2012) 3.62
Effects of normal, pre-hypertensive, and hypertensive blood pressure levels on progression of coronary atherosclerosis. J Am Coll Cardiol (2006) 3.54
Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes. N Engl J Med (2017) 3.53
Effect of two intensive statin regimens on progression of coronary disease. N Engl J Med (2011) 3.52
Bare metal stent restenosis is not a benign clinical entity. Am Heart J (2006) 3.39
Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials. BMJ (2008) 3.35
Global risk scores and exercise testing for predicting all-cause mortality in a preventive medicine program. JAMA (2004) 3.34
Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation (2011) 3.30
Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. JAMA (2007) 3.25
Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspective. Thromb Haemost (2011) 3.16
Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials. Circulation (2012) 3.14
Bariatric surgery improves the metabolic profile of morbidly obese patients with type 1 diabetes. Diabetes Care (2014) 3.13
Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials. Am J Cardiol (2005) 3.05
Role of aspiration and mechanical thrombectomy in patients with acute myocardial infarction undergoing primary angioplasty: an updated meta-analysis of randomized trials. J Am Coll Cardiol (2013) 2.99
Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease. Ann Intern Med (2010) 2.97
Carotid artery stenting vs carotid endarterectomy: meta-analysis and diversity-adjusted trial sequential analysis of randomized trials. Arch Neurol (2010) 2.83
Association of socioeconomic status with functional capacity, heart rate recovery, and all-cause mortality. JAMA (2006) 2.82
Aspirin and clopidogrel resistance: an emerging clinical entity. Eur Heart J (2005) 2.80
Heart rate recovery after exercise is a predictor of mortality, independent of the angiographic severity of coronary disease. J Am Coll Cardiol (2003) 2.76
CPAP versus oxygen in obstructive sleep apnea. N Engl J Med (2014) 2.75
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol (2008) 2.67
Predictors of adherence to performance measures in patients with acute myocardial infarction. Am J Med (2012) 2.64
Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA (2013) 2.62
Variability in platelet responsiveness to clopidogrel among 544 individuals. J Am Coll Cardiol (2005) 2.59
Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol (2010) 2.55
Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci. Am J Hum Genet (2012) 2.53
Living alone and cardiovascular risk in outpatients at risk of or with atherothrombosis. Arch Intern Med (2012) 2.53
Metformin use and mortality among patients with diabetes and atherothrombosis. Arch Intern Med (2010) 2.52
Platelet inhibition with cangrelor in patients undergoing PCI. N Engl J Med (2009) 2.52
Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol (2011) 2.46
Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Diabetes (2008) 2.42
Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials. Am J Med (2006) 2.38
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev (2014) 2.35
Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden. Circulation (2008) 2.34
An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial. Eur Heart J (2007) 2.31
High-dose statins in acute coronary syndromes: not just lipid levels. JAMA (2004) 2.31
Impact of navigators on completion of steps in the kidney transplant process: a randomized, controlled trial. Clin J Am Soc Nephrol (2012) 2.30
Aspirin and clopidogrel in acute coronary syndromes: therapeutic insights from the CURE study. Arch Intern Med (2003) 2.29
Haemoglobin targets: we were wrong, time to move on. Lancet (2007) 2.26
Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events. Stroke (2004) 2.24
HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database Syst Rev (2013) 2.21
Left main trunk coronary artery dissection as a consequence of inaccurate coronary computed tomographic angiography. Arch Intern Med (2010) 2.21
Exercise-induced reversal of insulin resistance in obese elderly is associated with reduced visceral fat. J Appl Physiol (1985) (2005) 2.18
Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET). J Am Coll Cardiol (2003) 2.17
Statins and intracerebral hemorrhage: collaborative systematic review and meta-analysis. Circulation (2011) 2.17
Influence of pouch and stoma size on weight loss after gastric bypass. Surg Obes Relat Dis (2011) 2.16
A prospective, randomized trial of single-drug versus dual-drug immunosuppression in heart transplantation: the tacrolimus in combination, tacrolimus alone compared (TICTAC) trial. Circ Heart Fail (2011) 2.15
Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis. Am Heart J (2008) 2.09